GT Biopharma Inc
GTBP
$5.24-13.04%
End of day · as of Sep 9, 2026, 7:01 AM ET
Mkt cap
$17.43M
EV/Sales
N/A
P/E ratio
N/A
FY2020 Revenue
N/A
EPS (FY2020)
N/A
Gross Margin (FY2020)
N/A
Profit Margin (FY2020)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
Latest reported GTBP revenue for 2020-12-31 was $0. Net income was -$28.3M. GTBP currently screens at market cap $17.4M.
Use this GTBP research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full GTBP income, balance, and cash tables.
GT Biopharma Inc (GTBP) is a biotechnology company in the Healthcare sector.
Latest cached GT Biopharma Inc (GTBP) net income for Dec 31, 2020 was -$28.3M. Statements: https://lician.com/financials/gtbp
GT Biopharma Inc (GTBP) market capitalization is $17.4M on the latest cached snapshot.
GT Biopharma Inc (GTBP) cached previous close $6.03; day range $4.91 – $5.95; volume 86,418. Session quote: https://lician.com/quote/gtbp
The latest cached GTBP filing is 8-K · Sep 25, 2026. Filings: https://lician.com/sec/gtbp